:ibrutinib

Jason B Gibbons1, Charles L Bennett, Kenneth R Carson

  • 1Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205.

概括

"通货膨胀减缓法案"允许从2024年开始就医疗保险药品价格进行谈判. 通过检查制造商特定的定价信息,对ibrutinib数据的分析为潜在的医疗保险谈判策略提供了信息.